Last Updated on January 12, 2024 by The Health Master
Granules India announced that Granules Pharmaceuticals, located in Chantilly, Virginia, has successfully completed the United States Food and Drug Administration (USFDA) Post-Marketing Adverse Drug Experience (PADE) Inspection for all its entities in the US, including Granules India.
The inspection was closed with zero observations on Form 483.
The inspection was conducted at Granules Pharmaceuticals from July 31, 2023, to August 03, 2023.
This inspection covered the Granules’ PADE surveillance, receipts, evaluations, processing, and reporting system for the marketed drug products worldwide.
This is Granules India’s fourth USFDA audit since March, with zero observations.
Understanding GMP, cGMP, and WHO-GMP
USFDA concludes inspection at Gland Pharma with zero observation
USFDA Warning Letter resolved: Lupin, Goa, Pithampur
USFDA concludes inspection at Eugia Pharma with zero observation
USFDA issues Form 483 with 3 observations to Aurobindo: Hyderabad
USFDA issues Form 483 with 8 observations to Biocon: Malaysia
USFDA issues Form 483 with one observation to Gland Pharma: Hyderabad
Legal Metrology Division urges to ensure compliance of Rules 26 on…
Major Crackdown: Rs 2 Crore-worth counterfeit drugs seized in Kolkata
Positive Govt response awaited for New Regulation on OTC Drugs
Quality Assurance in the Pharmaceutical Industry
Drug Dept cautions consumers about 15 NSQ drugs in circulation: Karnataka
Govt prohibits Ketoprofen and Aceclofenac formulations for Animal Use
Govt to implement GMP for Pharma Companies to enhance quality and global acceptance
NIPER: A Comprehensive Guide to NIPER Institutes in India
Illegal Drugs worth more than Rs. 50 Lakh seized from warehouses in Agra
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
